Andrew James King
CIK 1823187 · See Remarks · last filed 2026-02-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.92M
Companies
2
Total Filings
21
Lifetime Open-Market Net
-$1.06M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JBIO | See Remarks | 386,113 | $15.34 | $5.92M | $0 | 1 | 2026-02-13 |
| CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Chief Scientific Officer | 0 | $40.39 | $0 | -$1.06M | 20 | 2023-08-11 |
Recent Filings · Page 3 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-10-07 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–21 of 21
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.